181 related articles for article (PubMed ID: 36306784)
1. Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition.
Chen WH; Kim J; Bu W; Board NL; Tsybovsky Y; Wang Y; Hostal A; Andrews SF; Gillespie RA; Choe M; Stephens T; Yang ES; Pegu A; Peterson CE; Fisher BE; Mascola JR; Pittaluga S; McDermott AB; Kanekiyo M; Joyce MG; Cohen JI
Immunity; 2022 Nov; 55(11):2135-2148.e6. PubMed ID: 36306784
[TBL] [Abstract][Full Text] [Related]
2. Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells.
Bu W; Joyce MG; Nguyen H; Banh DV; Aguilar F; Tariq Z; Yap ML; Tsujimura Y; Gillespie RA; Tsybovsky Y; Andrews SF; Narpala SR; McDermott AB; Rossmann MG; Yasutomi Y; Nabel GJ; Kanekiyo M; Cohen JI
Immunity; 2019 May; 50(5):1305-1316.e6. PubMed ID: 30979688
[TBL] [Abstract][Full Text] [Related]
3. The Cytoplasmic Tail Domain of Epstein-Barr Virus gH Regulates Membrane Fusion Activity through Altering gH Binding to gp42 and Epithelial Cell Attachment.
Chen J; Jardetzky TS; Longnecker R
mBio; 2016 Nov; 7(6):. PubMed ID: 27935841
[TBL] [Abstract][Full Text] [Related]
4. Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350.
Cui X; Cao Z; Chen Q; Arjunaraja S; Snow AL; Snapper CM
Vaccine; 2016 Jul; 34(34):4050-5. PubMed ID: 27291087
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus gH/gL and Kaposi's Sarcoma-Associated Herpesvirus gH/gL Bind to Different Sites on EphA2 To Trigger Fusion.
Chen J; Schaller S; Jardetzky TS; Longnecker R
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847853
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells.
Bu W; Kumar A; Board NL; Kim J; Dowdell K; Zhang S; Lei Y; Hostal A; Krogmann T; Wang Y; Pittaluga S; Marcotrigiano J; Cohen JI
Immunity; 2024 Mar; 57(3):559-573.e6. PubMed ID: 38479361
[TBL] [Abstract][Full Text] [Related]
7. Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.
Perez EM; Foley J; Tison T; Silva R; Ogembo JG
Oncotarget; 2017 Mar; 8(12):19255-19273. PubMed ID: 27926486
[TBL] [Abstract][Full Text] [Related]
8. A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice.
Wei CJ; Bu W; Nguyen LA; Batchelor JD; Kim J; Pittaluga S; Fuller JR; Nguyen H; Chou TH; Cohen JI; Nabel GJ
Sci Transl Med; 2022 May; 14(643):eabf3685. PubMed ID: 35507671
[TBL] [Abstract][Full Text] [Related]
9. An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus.
Snijder J; Ortego MS; Weidle C; Stuart AB; Gray MD; McElrath MJ; Pancera M; Veesler D; McGuire AT
Immunity; 2018 Apr; 48(4):799-811.e9. PubMed ID: 29669253
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus Fusion with Epithelial Cells Triggered by gB Is Restricted by a gL Glycosylation Site.
Möhl BS; Chen J; Park SJ; Jardetzky TS; Longnecker R
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956769
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of glycoprotein L (gL) from rhesus lymphocryptovirus in Epstein-Barr virus-mediated cell fusion indicates a direct role of gL in gB-induced membrane fusion.
Plate AE; Smajlović J; Jardetzky TS; Longnecker R
J Virol; 2009 Aug; 83(15):7678-89. PubMed ID: 19457993
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge.
Malhi H; Homad LJ; Wan YH; Poudel B; Fiala B; Borst AJ; Wang JY; Walkey C; Price J; Wall A; Singh S; Moodie Z; Carter L; Handa S; Correnti CE; Stoddard BL; Veesler D; Pancera M; Olson J; King NP; McGuire AT
Cell Rep Med; 2022 Jun; 3(6):100658. PubMed ID: 35705092
[TBL] [Abstract][Full Text] [Related]
13. A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge
Hong J; Zhong L; Zheng Q; Wu Q; Zha Z; Wei D; Chen H; Zhang W; Zhang S; Huang Y; Chen K; Chen J; Li S; Zeng MS; Zeng YX; Xia N; Zhang X; Xu M; Chen Y
J Virol; 2022 Apr; 96(8):e0007522. PubMed ID: 35348362
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.
Edwards KR; Schmidt K; Homad LJ; Kher GM; Xu G; Rodrigues KA; Ben-Akiva E; Abbott J; Prlic M; Newell EW; De Rosa SC; Irvine DJ; Pancera M; McGuire AT
Cell Rep Med; 2024 Jun; 5(6):101587. PubMed ID: 38781964
[TBL] [Abstract][Full Text] [Related]
15. Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge.
Cui X; Cao Z; Ishikawa Y; Cui S; Imadome KI; Snapper CM
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33808755
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex.
Matsuura H; Kirschner AN; Longnecker R; Jardetzky TS
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22641-6. PubMed ID: 21149717
[TBL] [Abstract][Full Text] [Related]
17. The Epstein-Barr virus (EBV) glycoprotein B cytoplasmic C-terminal tail domain regulates the energy requirement for EBV-induced membrane fusion.
Chen J; Zhang X; Jardetzky TS; Longnecker R
J Virol; 2014 Oct; 88(20):11686-95. PubMed ID: 25100836
[TBL] [Abstract][Full Text] [Related]
18. The KGD motif of Epstein-Barr virus gH/gL is bifunctional, orchestrating infection of B cells and epithelial cells.
Chen J; Rowe CL; Jardetzky TS; Longnecker R
mBio; 2012; 3(1):. PubMed ID: 22215569
[TBL] [Abstract][Full Text] [Related]
19. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
[TBL] [Abstract][Full Text] [Related]
20. Functional homology of gHs and gLs from EBV-related gamma-herpesviruses for EBV-induced membrane fusion.
Omerović J; Longnecker R
Virology; 2007 Aug; 365(1):157-65. PubMed ID: 17477951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
